OpenEvidence

OpenEvidence is a next-generation AI platform transforming how healthcare professionals and organizations access and apply medical information. Built on cutting-edge large language models and deep clinical data, OpenEvidence enables faster, more reliable, and more personalized decision-making for clinicians and life sciences partners.

Foundation models and researchHealth and bio

OpenEvidence raised $250M in a Series B+ round announced January 21, 2026, according to techcrunch.com. Across 4 sourced rounds it has raised $735M in total. Investors in that round: Thrive Capital.

Raise history

1. September 29, 2026
   First seen by Recent Funding
   via startups.gallery
2. January 21, 2026
   Series B+ · $250M
   TThrive Capital (lead)
   Source: techcrunch.com (startups.gallery listing)
3. October 20, 2025
   Round · $200M
   GGV (lead)
   Source: techcrunch.com (startups.gallery listing)
4. July 15, 2025
   Series B+ · $210M
   SSequoia (lead)
   Source: finsmes.com (startups.gallery listing)
5. February 20, 2025
   Series A · $75M
   SSequoia (lead)
   Source: axios.com (startups.gallery listing)

Investors

• BBlackstone
• BBreyer Capital
• CCoatue
• CConviction
• GGV
• KKleiner Perkins
• SSequoia
• TThrive Capital

Related other companies

• QQuartermaster$140M · Sep 28, 2026
• SSnorkel AI$350M · Sep 23, 2026
• EEnveda$311M · Sep 23, 2026
• HHeidi Health$100M · Sep 22, 2026
• FFirecrawl$75M · Sep 22, 2026
• CCorridor$25M · Sep 21, 2026
• JJack & Jill$40M · Sep 19, 2026
• MMithr Inc.$20M · Sep 19, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/openevidence.